These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6982428)

  • 1. Impaired permeability of the blood-cerebrospinal fluid barrier in hyperphenylalaninaemia.
    Piel N; Lane JD; Hüther G; Neuhoff V
    Neuropediatrics; 1982 May; 13(2):88-92. PubMed ID: 6982428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat.
    Hosoya K; Hori S; Ohtsuki S; Terasaki T
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1875-85. PubMed ID: 15381338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness and limitation of primary cultured porcine choroid plexus epithelial cells as an in vitro model to study drug transport at the blood-CSF barrier.
    Angelow S; Zeni P; Galla HJ
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1859-73. PubMed ID: 15381337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of the HIV protease inhibitor, ritonavir, to the brain, cerebrospinal fluid, and choroid plexuses of the guinea pig.
    Anthonypillai C; Sanderson RN; Gibbs JE; Thomas SA
    J Pharmacol Exp Ther; 2004 Mar; 308(3):912-20. PubMed ID: 14634041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant.
    Tachikawa M; Fujinawa J; Takahashi M; Kasai Y; Fukaya M; Sakai K; Yamazaki M; Tomi M; Watanabe M; Sakimura K; Terasaki T; Hosoya K
    J Neurochem; 2008 Nov; 107(3):768-78. PubMed ID: 18761709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for ascorbic acid transport system in rat brain capillaries.
    Ziylan YZ; Diler AS; Lefauconnier JM; Bourre JM
    Int J Neurosci; 2006 Jan; 116(1):25-38. PubMed ID: 16318997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular transfer of macromolecules across the developing choroid plexus of Monodelphis domestica.
    Liddelow SA; Dziegielewska KM; Ek CJ; Johansson PA; Potter AM; Saunders NR
    Eur J Neurosci; 2009 Jan; 29(2):253-66. PubMed ID: 19200232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active transport at the blood-CSF barrier contributes to manganese influx into the brain.
    Schmitt C; Strazielle N; Richaud P; Bouron A; Ghersi-Egea JF
    J Neurochem; 2011 May; 117(4):747-56. PubMed ID: 21395586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenylalanine concentration in the cerebrospinal fluid and blood, both entering and leaving the brain, of phenylketonuria patients].
    Bulakhova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1542-6. PubMed ID: 4775335
    [No Abstract]   [Full Text] [Related]  

  • 11. Brain protection at the blood-cerebrospinal fluid interface involves a glutathione-dependent metabolic barrier mechanism.
    Ghersi-Egea JF; Strazielle N; Murat A; Jouvet A; Buénerd A; Belin MF
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1165-75. PubMed ID: 16395287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEPT2 (Slc15a2)-mediated unidirectional transport of cefadroxil from cerebrospinal fluid into choroid plexus.
    Shen H; Keep RF; Hu Y; Smith DE
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1101-8. PubMed ID: 16107517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and peptide analog transport systems at the blood-CSF barrier.
    Smith DE; Johanson CE; Keep RF
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1765-91. PubMed ID: 15381333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.
    Ratzmann GW; Grimm U; Jährig K; Knapp A
    Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific AHNAK expression in brain endothelial cells with barrier properties.
    Gentil BJ; Benaud C; Delphin C; Remy C; Berezowski V; Cecchelli R; Feraud O; Vittet D; Baudier J
    J Cell Physiol; 2005 May; 203(2):362-71. PubMed ID: 15493012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process.
    Tachikawa M; Kasai Y; Takahashi M; Fujinawa J; Kitaichi K; Terasaki T; Hosoya K
    J Neurochem; 2008 Oct; 107(2):432-42. PubMed ID: 18752646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transport of gentamicin in the choroid plexus and cerebrospinal fluid.
    Spector R
    J Pharmacol Exp Ther; 1975 Jul; 194(1):82-8. PubMed ID: 1151757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
    Strazielle N; Khuth ST; Ghersi-Egea JF
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1717-40. PubMed ID: 15381331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of nutrients across the choroid plexus.
    Segal MB
    Microsc Res Tech; 2001 Jan; 52(1):38-48. PubMed ID: 11135447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2.
    Khuth ST; Strazielle N; Giraudon P; Belin MF; Ghersi-Egea JF
    J Neurochem; 2005 Sep; 94(6):1580-93. PubMed ID: 16026393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.